2024-11-13 01:03:58,912 - INFO - Using LLM: gpt
2024-11-13 01:03:58,912 - INFO - Serialized input conversation. Now generating report skeleton...
2024-11-13 01:04:49,728 - INFO - Using LLM: gpt
2024-11-13 01:04:49,728 - INFO - Serialized input conversation. Now generating report skeleton...
2024-11-13 01:05:02,092 - INFO - Report skeleton generated: [{'heading': 'Introduction', 'sub_headings': []}, {'heading': 'Comprehensive Problem Statement on GPR119 and Metabolic Diseases', 'sub_headings': ['Overview', 'Diseases Linked with GPR119', 'Mechanism of Action', 'Physiological Role of GPR119', 'Therapeutic Implications', 'Conclusion']}, {'heading': 'Detailed Explanation of the Role of GPR119 Activation in Managing NAFLD', 'sub_headings': ['Mechanisms of GPR119 Activation', 'Physiological Impact on NAFLD', 'Conclusion']}, {'heading': 'Current Clinical Trials on GPR119 Activation for NAFLD Treatment', 'sub_headings': ['Overview of Ongoing Clinical Trials', 'Mechanistic Insights and Therapeutic Targets', 'Conclusion']}, {'heading': 'Comprehensive Analysis of Primary Endpoints in Clinical Trials for NAFLD: GPR119 Activation vs. Traditional Treatments', 'sub_headings': ['Efficacy Endpoints Comparison', 'Safety Outcomes Comparison', 'Novel Metrics Introduced by GPR119-Focused Trials', 'Visualization of Endpoint Focus Shift', 'Conclusion']}, {'heading': 'Common Side Effects of GPR119 Agonists in NAFLD Clinical Trials', 'sub_headings': ['Table: Side Effects Observed in Clinical Trials', 'Graphical Representation of Side Effect Pathways', 'Conclusion']}, {'heading': 'Potential Drug Interactions of GPR119 Agonists in NAFLD Treatment', 'sub_headings': ['Key Considerations for Drug Interactions', 'Impact on Efficacy and Safety', 'Visual Representation of Interactions', 'Conclusion']}, {'heading': 'Integration of GPR119 Agonists in NAFLD Treatment Regimens', 'sub_headings': ['Mechanistic Insights into GPR119 Agonists', 'Interaction with Common NAFLD Medications', 'Evaluating Drug-Drug Interactions and Efficacy', 'Clinical Considerations and Monitoring', 'Conclusion']}, {'heading': 'Comprehensive Analysis of GPR119 Agonists in the Treatment of Rare Diseases Including NAFLD', 'sub_headings': ['Potential Rare Diseases Targeted by GPR119 Agonists', 'Mechanisms of GPR119 Agonists in NAFLD Treatment', 'Current Research and Clinical Trials', 'Conclusion']}, {'heading': 'Utilization of GPR119 Agonists in Prader-Willi Syndrome Treatment', 'sub_headings': ['Mechanism of Action of GPR119 Agonists', 'Therapeutic Benefits in Prader-Willi Syndrome', 'Clinical Research and Trials', 'Potential Challenges and Considerations', 'Conclusion']}, {'heading': 'Comprehensive Analysis of GPR119 Agonists for Managing Prader-Willi Syndrome (PWS)', 'sub_headings': ['Mechanisms of Action', 'Clinical Outcomes and Efficacy', 'Side Effects', 'Patient Response Data', 'Comparative Analysis', 'Conclusion']}]

Now generating report sections with `section_dedup` set to True...
2024-11-13 01:08:49,937 - INFO - Using LLM: gpt
2024-11-13 01:08:49,937 - INFO - Serialized input conversation. Now generating report skeleton...
2024-11-13 01:09:09,122 - INFO - Report skeleton generated: [{'heading': 'Introduction', 'sub_headings': ['Objective of the Report', 'Overview of GPR119 and its Role in Metabolic Diseases']}, {'heading': 'Background', 'sub_headings': ['Understanding GPR119', 'Mechanisms of Action in Metabolic Regulation']}, {'heading': 'Methodology', 'sub_headings': ['Data Collection and Analysis Methods', 'Clinical Trial Evaluation Criteria']}, {'heading': 'Findings', 'sub_headings': ['Diseases Linked with GPR119', 'Therapeutic Implications in NAFLD', 'Clinical Trials and Efficacy of GPR119 Agonists']}, {'heading': 'Discussion', 'sub_headings': ['Comparison with Traditional Treatments', 'Potential for Treating Rare Diseases', 'Drug Interaction Considerations']}, {'heading': 'Conclusion', 'sub_headings': ['Summary of Key Findings', 'Implications for Future Research']}, {'heading': 'Recommendations', 'sub_headings': ['Clinical Application of GPR119 Agonists', 'Future Research Directions']}]

Now generating report sections with `section_dedup` set to True...
2024-11-13 01:12:48,578 - INFO - HTML report successfully generated! Converting HTML to PDF file now!
2024-11-13 01:20:39,253 - INFO - Using LLM: gpt
2024-11-13 01:20:39,254 - INFO - Serialized input conversation. Now generating report skeleton...
2024-11-13 01:20:51,169 - INFO - Report skeleton generated: [{'heading': 'Introduction', 'sub_headings': ['Purpose of the Report', 'Overview of GPR119 and Its Role in Metabolic Diseases', 'Scope of the Report']}, {'heading': 'Background', 'sub_headings': ['Expression and Function of GPR119', 'Diseases Associated with GPR119 Activation']}, {'heading': 'Mechanism of Action', 'sub_headings': ['Insulin and Incretin Modulation', 'Energy Metabolism and Satiety']}, {'heading': 'Findings', 'sub_headings': ['Therapeutic Implications for Type 2 Diabetes', 'Potential Benefits for Non-Alcoholic Fatty Liver Disease', 'Role in Prader-Willi Syndrome']}, {'heading': 'Discussion', 'sub_headings': ['Comparison with Traditional Treatment Options', 'Potential Drug Interactions', 'Side Effects and Safety Profile']}, {'heading': 'Current Clinical Trials', 'sub_headings': ['Overview of Ongoing Trials', 'Primary Endpoints Comparison with Traditional Treatments']}, {'heading': 'Conclusion', 'sub_headings': ['Summary of Key Findings', 'Implications for Future Research']}, {'heading': 'Recommendations', 'sub_headings': ['Potential for Integrating GPR119 Agonists in Treatment Regimens', 'Areas for Further Study']}]

Now generating report sections with `section_dedup` set to True...
2024-11-13 01:24:57,043 - INFO - HTML report successfully generated! Converting HTML to PDF file now!
2024-11-13 01:25:06,333 - INFO - PDF report on Exploring GPR119 Agonists in Metabolic Disease Therapies: A Focus on NAFLD and Prader-Willi Syndrome generated and saved to c:\Users\pangc\Downloads\MaprangEX\EzyQuant Template\Confirm\ReportAI\reportAI\report_ai\reports\Exploring_GPR119_Agonists_in_Metabolic_Disease_Therapies__A_Focus_on_NAFLD_and_Prader-Willi_Syndrome.pdf
2024-11-13 03:15:48,156 - INFO - Using LLM: gpt
2024-11-13 03:15:48,157 - INFO - Serialized input conversation. Now generating report skeleton...
2024-11-13 03:15:56,157 - INFO - Report skeleton generated: [{'heading': 'Introduction', 'sub_headings': ['Purpose of the Report', 'Overview of Data Sources and Methodology']}, {'heading': 'Asset Structure Analysis', 'sub_headings': ['Current vs. Non-Current Assets', 'Detailed Asset Analysis']}, {'heading': 'Debt Structure Analysis', 'sub_headings': ['Debt-Asset Alignment', 'Debt Ratios']}, {'heading': 'Equity Analysis', 'sub_headings': ['Accumulated Losses', 'Quasi-Debt Instruments']}, {'heading': 'Profit and Loss Statement Analysis', 'sub_headings': ['Revenue and Profitability Overview', 'Detailed Profit Analysis', 'Red Flags to Watch For']}, {'heading': 'Cash Flow Analysis', 'sub_headings': ['Cash Flow from Operations', 'Cash Flow from Investing Activities', 'Cash Flow from Financing Activities', 'Key Concerns to Watch For']}, {'heading': 'Financial Ratio Analysis', 'sub_headings': ['Key Ratios for Evaluation', 'Conclusion']}, {'heading': 'Growth Potential Analysis', 'sub_headings': ['Industry Context', 'Financial Indicators of Growth', 'Red Flags to Watch For']}, {'heading': 'Valuation Analysis', 'sub_headings': ['Price-to-Earnings (P/E) Ratio', 'Other Valuation Metrics', 'Market Sentiment and Concerns']}, {'heading': 'Conclusion', 'sub_headings': ['Summary of Key Findings', 'Final Remarks and Insights']}]

Now generating report sections with `section_dedup` set to True...
2024-11-13 03:20:11,104 - INFO - HTML report successfully generated! Converting HTML to PDF file now!
2024-11-13 03:20:18,048 - INFO - PDF report on Comprehensive Stock Analysis Report for PTT generated and saved to c:\Users\pangc\Downloads\MaprangEX\EzyQuant Template\Confirm\ReportAI\reportAI\report_ai\reports\Comprehensive_Stock_Analysis_Report_for_PTT.pdf
2024-11-13 03:45:43,192 - INFO - Using LLM: gpt
2024-11-13 03:45:43,192 - INFO - Serialized input conversation. Now generating report skeleton...
2024-11-13 03:45:52,380 - INFO - Report skeleton generated: [{'heading': 'Introduction', 'sub_headings': ['Objective of the Report', 'Data Sources and Methodology']}, {'heading': 'Asset Structure Analysis', 'sub_headings': ['Current vs. Non-Current Assets', 'Detailed Asset Analysis']}, {'heading': 'Debt Structure Analysis', 'sub_headings': ['Debt-Asset Alignment', 'Debt Ratios']}, {'heading': 'Equity Analysis', 'sub_headings': ['Accumulated Losses', 'Quasi-Debt Instruments']}, {'heading': 'Conclusion', 'sub_headings': ['Summary of Financial Health', 'Key Insights and Monitoring Points']}, {'heading': 'Profit and Loss Statement Analysis', 'sub_headings': ['Revenue and Profitability Overview', 'Detailed Profit Analysis', 'Red Flags to Watch For']}, {'heading': 'Cash Flow Analysis', 'sub_headings': ['Cash Flow from Operations', 'Cash Flow from Investing Activities', 'Cash Flow from Financing Activities', 'Key Concerns to Watch For']}, {'heading': 'Financial Ratio Analysis', 'sub_headings': ['Key Ratios for Evaluation', 'Conclusion of Ratio Analysis']}, {'heading': 'Growth Potential Analysis', 'sub_headings': ['Industry Context', 'Financial Indicators of Growth', 'Red Flags to Watch For', 'Conclusion on Growth Potential']}, {'heading': 'Valuation Analysis', 'sub_headings': ['Price-to-Earnings (P/E) Ratio', 'Other Valuation Metrics', 'Market Sentiment and Concerns', 'Conclusion on Valuation']}]

Now generating report sections with `section_dedup` set to True...
2024-11-13 03:50:02,754 - INFO - HTML report successfully generated! Converting HTML to PDF file now!
2024-11-13 03:50:11,742 - INFO - PDF report on Comprehensive Stock Analysis Report for SCC generated and saved to c:\Users\pangc\Downloads\MaprangEX\EzyQuant Template\Confirm\ReportAI\reportAI\report_ai\reports\Comprehensive_Stock_Analysis_Report_for_SCC.pdf
